Practice Guideline Track on Myocardial Revascularization

Guidelines into Practice

Topic(s):

Chronic Ischaemic Heart Disease (IHD)

Cardiovascular Surgery

Contributor: Special thanks to Stuart Head from the Task Force on Myocardial Revascularization of ESC and EACTS, with contribution of EAPCI.

Based on the 2014 ESC/EACTS Guidelines in Myocardial Revascularisation.

Webinars on this topic

2016 ESC General Cardiology webinar, "Myocardial revascularization : how have the guidelines changed our practice" Watch the recording.

2015 ESC General Cardiology webinar, the multidiscplinary heart team discussions on "Diabetic patient with stable angina" Watch the recording.

Part 1 - Overview of the 2014 ESC/EACTS Guidelines on Myocardial Revascularization

Session	Presentation	Slides	Webcast
ESC 2014 Guidelines overview	Myocardial revascularization
ESC/EACTS Guidelines on Myocardial Revasularization	Strength of a joint ESC/EACTS Task Force
	Risk assessment and patient information
	Revascularization in patients with stable coronary artery disease
	Revascularization in patients with coronary artery disease and associated conditions
	Antithrombotic therapy in patients undergoing revascularization
Take home messages for practitioners	Concluding remarks
Take home messages for practitioners	Coronary artery disease update 2014
Meet the Guidelines Task Force I	Myocardial revascularization

Part 2: Topics in focus

Topic	Session Title	Slides	Webcast
IMAGING	Optimal non-invasive strategy to detect worsening and severe ischaemia
IMAGING	High risk patients with stable angina. When coronary angiography should be the first choice
SCAD	Coronary artery bypass surgery is the best option
	A fractional flow reserve-guided PCI is a valid alternative
	Left main disease: the surgeon's view
	How to individualise the revascularisation treatment?
	Fractional flow reserve-guided PCI versus medical treatment in stable coronary disease: FAME 2 primary end-point data analysis
NSTE-ACS	Revascularization in high risk NSTEMI
NSTE-ACS	NSTEMI: cath lab now or later?
STEMI	Is there (still) a role for thrombectomy in STEMI
STEMI	STEMI: essential questions in primary PCI
CARDIOGENIC SHOCK	Primary PCI: culprit lesion or immediate complete reveascularization?
CARDIOGENIC SHOCK	Percutaneous support: when and how
DIABETES	Revascularization in diabetes patients: CABG versus PCI
VALVE INTERVENTIONS	More aortic stenosis than coronary artery disease
VALVE INTERVENTIONS	Combined aortic stenosis and coronary artery disease: conclusions and general take home message
REPEAT PROCEDURES	Stent thrombosis and restenosis: what have we learned and where are we going?
PCI	Optical coherence tomography: just nice to have or mandatory?
ANTITHROMBOTIC	When to stop dual antiplatelet therapy after ACS - less is more?
	Early initiation of antiplatelet therapy - Recommendations and current practice
	Upstream versus intraprocedural antiplatelet therapy
	Pre-treatment with P2Y12 inhibitors in acute coronary syndrome. PRO and CONTRA
	Complete versus Lesion only Primary-PCI Trial (CvLPRIT): treat the infarct related artery only or all lesions.
	Bivalirudin as anticoagulant in primary PCI - pros and cons

Show navigation Hide navigation

Practice Guideline Track on Myocardial Revascularization

Guidelines into Practice

Webinars on this topic

Part 1 - Overview of the 2014 ESC/EACTS Guidelines on Myocardial Revascularization

Part 2: Topics in focus